Literature DB >> 22325661

Gynaecological cancers in pregnancy.

Philippe Morice1, Catherine Uzan, Sebastien Gouy, Claire Verschraegen, Christine Haie-Meder.   

Abstract

Cervical and ovarian cancers are the most common gynaecological cancers diagnosed during pregnancy. In early-stage cervical cancer during the first and at the beginning of the second trimester, the two main considerations for management of the patient are the tumour size (and stage) and nodal staging. MRI and laparoscopic lymphadenectomy are useful for clinicians planning a potentially conservative approach. The management of patients with locally advanced cervical disease is controversial and should be discussed on a case-by-case basis according to the tumour size, radiological findings, the term of pregnancy, and the patient's wishes. Different histological types of malignant ovarian diseases arise during pregnancy and their management depends on the diagnosis (histological subtypes, tumour differentiation, and nodal status), the tumour stage, and the trimester of the pregnancy. In patients with peritoneal spread or high-risk early-stage disease, neoadjuvant chemotherapy with pregnancy preservation could be appropriate.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22325661     DOI: 10.1016/S0140-6736(11)60829-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  51 in total

1.  Malignancies associated with pregnancy: an analysis of 21 clinical cases.

Authors:  Y Liu; Y Liu; Y Wang; X Chen; H Chen; J Zhang
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

Review 2.  Management of gynecological cancers during pregnancy.

Authors:  Sileny N Han; Magali Verheecke; Tineke Vandenbroucke; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Curr Oncol Rep       Date:  2014-12       Impact factor: 5.075

3.  Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.

Authors:  Sileny N Han; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

4.  [Pregnancy-preserving and maternal-fetal management in a patient with rare large cell neuroendocrine carcinoma of the uterine cervix].

Authors:  Dai Geyang; Chen Gaowen; L I Xiaoxuan; Zheng Youhong; Wang Yuan; Li Xingsong; L I Jing; Zhou Jing; Xie Yu; Wang Yifeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

5.  Robotic-assisted surgery for the treatment of pelvic masses in pregnant patients: a series of four cases and literature review.

Authors:  Alberto A Mendivil; John V Brown; Lisa N Abaid; Mark A Rettenmaier; John P Micha; Marie A Wabe; Bram H Goldstein
Journal:  J Robot Surg       Date:  2013-01-18

6.  Pregnancy-Associated Cancer: A U.S. Population-Based Study.

Authors:  Carrie M Cottreau; Inna Dashevsky; Susan E Andrade; De-Kun Li; Larissa Nekhlyudov; Marsha A Raebel; Debra P Ritzwoller; Ann H Partridge; Pamala A Pawloski; Sengwee Toh
Journal:  J Womens Health (Larchmt)       Date:  2018-10-10       Impact factor: 2.681

Review 7.  Therapeutic management of epithelial ovarian cancer during pregnancy.

Authors:  L Minig; L Otaño; I Diaz-Padilla; R Alvarez Gallego; M G Patrono; J Valero de Bernabé
Journal:  Clin Transl Oncol       Date:  2012-11-21       Impact factor: 3.405

8.  A Japanese survey of malignant disease in pregnancy.

Authors:  Yoshiyuki Kobayashi; Tsutomu Tabata; Mayu Omori; Eiji Kondo; Toru Hirata; Kenta Yoshida; Masayuki Sekine; Atsuo Itakura; Takayuki Enomoto; Tomoaki Ikeda
Journal:  Int J Clin Oncol       Date:  2018-10-27       Impact factor: 3.402

9.  Treatment and clinical outcomes of cervical cancer during pregnancy.

Authors:  Jing Ma; Lan Yu; Fan Xu; Hongyan Yi; Wenfei Wei; Peng Wu; Sha Wu; Hua Li; Hong Ye; Wei Wang; Hui Xing; Liangsheng Fan
Journal:  Ann Transl Med       Date:  2019-06

Review 10.  Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Obstet Gynecol Surv       Date:  2017-03       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.